Disclaimer

This website contains material about Nestlé Health Science products. Nestlé provides this material for the information and education of Health Care Professionals. If you choose to view this material, you are accepting that:

  • You are a Health Care Professional.
  • This material is supplied at your individual request, for educational purposes.
  • This material does not substitute for, or replace, the advice of a qualified Health Care Professional.
  • The material is provided for professional use only and must not be used for any other purpose.

I AGREEI DON’T AGREE

IS OPTIFAST® VLCD™ SUITABLE FOR DIABETES?

Most overweight and obese patients with Type 1 or Type 2 diabetes are eligible to use OPTIFAST® VLCD™ as part of an overall management program that emphasises the importance of ongoing weight maintenance. Special care is needed when managing patients with diabetes, as a VLCD significantly reduces plasma glucose concentration independently of weight loss. For this reason, hypoglycaemia is likely to occur if insulin or sulphonylureas are not reduced or stopped.

1. Most overweight and obese patients with Type 1 diabetes can consider using OPTIFAST® VLCD™.

2. Due to the risk of hypoglycaemia, it is imperative that blood glucose levels are monitored more frequently for the first few days (at least 4 times per day – once before each meal and before going to bed).

3. The aim is to prevent hypoglycaemia from occurring. Therefore, it is imperative that you work with your patient to get the insulin dosage right.

4. It is extremely important that insulin treatment is continued, no matter how low the insulin dose is. Do not completely cease insulin treatment.

1. Most obese patients with Type 2 diabetes can consider using OPTIFAST® VLCD™ as part of an overall weight management program.

2. If your patient is not on any insulin or taking Metformin, thiazolidenediones or acarbose, then they should benefit, like non-diabetic patients from the hunger-suppressing effects of mild ketosis.

3. Hypoglycaemia is a risk for patients on insulin or sulphonylureas therefore it is imperative that blood glucose levels are monitored more frequently for the first few days (at least 4 times per day – once before each meal and before going to bed).

4. The aim is to prevent hypoglycaemic episodes from occurring therefore it is imperative that you work with your patient to get their medication dosage right.



SHAKES
  • Product

  • GI Value

  • Carbohydrates(g/serve)

  • OPTIFAST® VLCD™ Chocolate Shake

  • 31

  • 22.5

  • OPTIFAST® VLCD™ Vanilla Flavour Shake

  • 27

  • 22.5

  • OPTIFAST® VLCD™ Strawberry Flavour Shake

  • 27

  • 22.5

BARS
  • Product

  • GI Value

  • Carbohydrates(g/serve)

  • OPTIFAST® VLCD™ Berry Crunch Flavour Bar

  • 25

  • 20.8

  • OPTIFAST® VLCD™ Cappuccino Flavour Bar

  • 29

  • 20.4

SOUPS
  • Product

  • GI Value

  • Carbohydrates(g/serve)

  • OPTIFAST® VLCD™ Chicken Flavour Soup

  • 31

  • 17

  • OPTIFAST® VLCD™ Tomato Soup

  • 25

  • 22

DESSERTS
  • Product

  • GI Value

  • Carbohydrates(g/serve)

  • OPTIFAST® VLCD™ Chocolate Dessert

  • 27

  • 17

  • OPTIFAST® VLCD™ Lemon Crème Flavour Dessert

  • 27

  • 17

About cookies on this site

Our site uses cookies and other technologies so that we, and our partners, can remember you and understand how you use our site. Further use of this site will be considered consent. For more information, visit our Privacy Policy.

I have read and understood the Nestlé Privacy Notice. Do not show this message again.
x